GENinCode (LON:GENI) Trading Down 9.7% – What’s Next?

GENinCode Plc (LON:GENIGet Free Report) shares traded down 9.7% on Thursday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.40 ($0.02). 19,180 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 598,022 shares. The stock had previously closed at GBX 1.55 ($0.02).

GENinCode Trading Down 9.7%

The firm has a market cap of £4.02 million, a price-to-earnings ratio of -55.34 and a beta of 0.66. The company has a debt-to-equity ratio of 9.28, a quick ratio of 15.89 and a current ratio of 2.60. The business has a fifty day moving average of GBX 1.67 and a two-hundred day moving average of GBX 2.14.

GENinCode Company Profile

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Further Reading

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.